PWRM, ACE, ABCD, ISTA, REDF- Stock Reports! from Stock-PR.com
12/29/2010 11:00:46 AM
FREE Daily Stock Alerts From
Power3 Medical Products, Inc. (PWRM.OB)
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading
proteomics company focused on the development of innovative diagnostic tests in
the fields of cancer and neurodegenerative diseases, today announced that
company management believes it is making great progress in its focus on the
development, sales, and marketing of its proprietary innovate diagnostic tests
for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain
neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a
In addition, Power3 is a party to several litigation matters, most of which
relate to various toxic debt instruments that were entered into by Power3
several years ago when it operated under the tenure of Chairman and CEO, Steven
B. Rash. Because current management believes these toxic debt instruments are
responsible for Power3’s depressed stock price and have distracted the company
from its mission, Power3 plans to settle as many of these nagging lawsuits as
possible prior to the completion of its merger with Rozetta-Cell Life Sciences,
Inc. As for those lawsuits that cannot be speedily resolved, Power3 will
continue to rigorously defend its position. For example, one such lawsuit
involves Neogenomics, Inc., which was recently granted a motion for summary
judgment with respect to an amount due under a convertible debenture. Power3
intends to appeal this decision.
“We are very excited to be finally ridding ourselves of litigation that has
plagued us for several years now,” stated Ira L. Goldknopf, President and Chief
Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the
future beginning with our upcoming acquisition of Rozetta-Cell and are about to
enter a long and substantial growth phase marked by advances in our science and
intellectual property. Given the imminent nature of many of these transactions
and breakthroughs, we have decided, in consultation with the financiers of
Rozetta-Cell, that the best course of action for Power3 is to settle many of
these lawsuits so that we can focus our attention exclusively on the acquisition
of Rozetta-Cell and the development of our combined businesses after the
Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that
focuses on the delivery and imaging of stem cells during therapy. Power3 plans
to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into
Power3, with Power3 remaining as the surviving company. The acquisition of
Rozetta-Cell is expected to be completed in February 2011.
Alzheimer’s declines ultimately. Alzheimer’s is a progressing sickness, in
which symptoms gradually worsen over a period of time. Continuing, memory loss
is minor, but with late-stage Alzheimer’s, people will not be able to hold on a
conversation and respond to their natural environment. Alzheimer’s disease is
the 6th major cause of loss of life in the USA. Some people that have
Alzheimer’s live life an average of eight years after their indications come to
be noticeable to other people, but survival can range from 3 to 20 years, based
on maturity and various health conditions.
Worldwide, breast cancer consists 10.4% in all cancer occurrence among the
ladies, rendering it the most common form of non-skin cancer in females and the
fifth most typical reason for cancer death. In ‘04, breast cancers triggered
519,000 fatalities across the world (7% associated with cancer deaths;
practically 1% of all deaths). Breast cancer is roughly a hundred situations
more established in females compared to men, despite the fact that males are apt
to have poorer successes on account of waiting times in a diagnosis.
Parkinson’s disease usually has an effect on people over 50 years old.
Beginning the signs of PD usually are subtle and happen gradually. Within a lot
of people the disease progresses more rapidly compared with others. Mainly
because the condition moves along, the shaking, or tremor, which is affecting
nearly all PD individuals may turn to interfere with every day actions.
Additional discomforts can sometimes include melancholy along with other
psychological changes; difficulties in swallowing, chewing, and speaking;
urinary problems or constipation; skin problems; and sleep disruptions.
Presently there are still simply no blood or laboratory tests which may support
in figuring out sporadic PD. Consequently the medical diagnosis is based on
track record including a neurological examination. The disease can often be
difficult to identify effectively. Physicians may very well in some cases
require brain scans or laboratory tests so that they can rule out other
ACE Limited (NYSE:ACE) announced recently that it has
completed its acquisition of Rain and Hail Insurance Service, Inc. for
approximately $1.1 billion in cash. The purchase price reflects a
dollar-for-dollar adjustment as required under the merger agreement to account
for an increase to Rain and Hail’s book value that occurred between December 31,
2009, and the closing of the transaction.
“We are pleased to now officially welcome this fine organization to ACE,”
said Evan G. Greenberg, Chairman and Chief Executive Officer of ACE Limited. “We
look forward to the benefits that the combination of our two organizations will
bring both in the near and longer term.”
Celebrating 25 years of insuring progress, the ACE Group is a leader in
insurance and reinsurance serving a diverse group of clients. Headed by ACE
Limited (NYSE:ACE - News), a component of the S&P 500 stock index, the ACE
Group conducts its business on a worldwide basis with operating subsidiaries in
more than 50 countries. Additional information can be found at: www.acegroup.com.
Cambium Learning Group, Inc. (Nasdaq:ABCD) announced that
its new corporate headquarters are now on the fourth floor of Briargrove Place
located at 17855 N. Dallas Parkway.Phone numbers, emails and the Company's
corporate website remain the same.Company contact information, Cambium Learning
Group, Inc., 17855 N. Dallas Parkway, Suite 400, Dallas, Texas 75287.
Learning Group, Inc. provides research-based education solutions for students in
the United States. Its Voyager segment provides various reading programs. This
segment?s reading programs include a reading intervention system; a literacy
program for students; an intervention program to accelerate reading for
struggling readers in middle and high school.
ISTA Pharmaceuticals Inc. (Nasdaq:ISTA) announced it will
conduct a 2011 guidance and pipeline update webcast/conference call after the
market closes on January 5, 2011.President and Chief Executive Officer, Vicente
Anido, Jr., Ph.D., and Chief Financial Officer and Vice President of Corporate
Development, Lauren Silvernail, will provide 2011 guidance, give a commercial
and new product pipeline update, and highlight key milestones for 2011. The
webcast/call will include a slide presentation; participants will be able to
view the accompanying slides through ISTA's website. After the call, the slides
will be available for download at http://www.istavision.com/investors.html
ISTA Pharmaceuticals, Inc., a pharmaceutical company,
discovers, develops, and markets remedies for diseases and conditions of the eye
in the United States. It provides products to treat diseases of the eye and
allergies; and therapies for ocular inflammation and pain, glaucoma, dry eye,
and ocular and nasal allergies.
Rediff.com India Ltd. (Nasdaq:REDF) announced their first 10
of ’10 list, the top 10 Bollywood songs of the year. The list is based on the
songs that users have been streaming on the service. The ranking takes into
account both traditional parameters like number of listeners and social
parameters like number of times the song was shared, number of comments on the
Rediff.com India Limited provides online Internet based services
with a focus on India and the global Indian community. Its Web sites consist of
interest specific channels relevant to Indian interests, including cricket;
astrology; matchmaker and movies; content on various matters, such as news and
finance; search facilities; a range of community features comprising e-mail,
chat, messenger, and e-commerce; and broadband wireless content.
Crown Equity Holdings Inc.
Crown Equity Holdings Inc. (OTCBB:CRWE) (http://www.crownequityholdings.com)
announced today that its subsidiary company, Crown Tele Services Inc. (http://www.crownteleservices.com )
is still moving forward after dissolving its joint venture with Communication
Expert Corporation and will gradually start rolling out its internet based voice
and video service IP-PBX solutions next year.
The cornerstone of Crown Tele Services Inc. strategy is to meet the highest
standards when it comes to delivering VoIP (Voice over Internet Protocol)
communication solutions specifically designed to meet the market needs.
Commenting on the venture, Kenneth Bosket, president said, “We are still
excited with this opportunity to expand our footprint in this valuable market.
The demand for internet-based voice and video services is growing exponentially
and our new subsidiary Crown Tele Services Inc. has launched its new website and
intends to emerge as a service provider of choice.”
According to ABI Research, the latest global business VoIP services forecasts
show that the value of the overall market, which includes VoIP integrated
access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is
set to double over the next five years, to exceed $20 billion by 2015.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY
Disclaimer: Never invest in any stock featured on our site or
emails unless you can afford to lose your entire investment. Stock-PR.com
publisher and its affiliates and contractors are not registered investment
advisers or broker/dealers. Our disclaimer is to be read and fully understood
before using our site, reading our newsletter or joining our email list. Release
of Liability: Through use of this website viewing or using, you agree to hold
Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators,
shareholders, employees and/or contractors harmless and to completely release
them from any and all liability due to any and all loss (monetary or otherwise),
damages (monetary or otherwise) that you may occur. (Read more
Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown
Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and
public awareness for both public and private companies, as well as disseminating
news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB)
advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges
an advertising fee which it must disclose under 17B. The fee may be in cash, in
free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB),
if paid in stock, can and may sell those securities during the advertising
period. Crown Equity Holdings Inc. (CRWE.OB) has received
1,000,000 shares 144 restricted stocks for IT department services and 2,000,000
shares (free trade) for 12 months of video production from Power 3 Medical
Products Inc. (PWRM.OB).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
The views expressed in any article, reports, writings are not necessarily the
views of Crown Equity Holdings Inc. its officers, directors, staff, contractors
or employees. They do not represent the views or opinions of this site. Views
expressed in articles are those of the author alone.